William Meury

SVP - Marketing, Forest Laboratories, LLC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jul 16, 2026Granted 26,807 shares of Incyte⁵
Jul 2, 2026Shares withheld for tax 4,779 shares at $116.86 of Incyte⁸
Apr 15, 2026Exercised options 125,000 shares of Incyte⁹
Jul 2, 2025Granted 36,101 shares of Incyte¹⁰
Feb 5, 2025Granted 25,000 shares of Syndax Pharmaceuticals Inc⁶
Mar 18, 2024Returned to company 19,037 shares at $330.00 of Karuna Therapeutics⁷
Mar 18, 2024Returned to company 10,342 shares at $330.00 of Karuna Therapeutics⁷
Feb 7, 2024Granted 17,000 shares of Syndax Pharmaceuticals Inc¹¹
Dec 28, 2023Shares withheld for tax 8,694 shares at $316.30 of Karuna Therapeutics¹²
Aug 2, 2023Sold 24,000 shares at $20.45 of Syndax Pharmaceuticals Inc¹³
Aug 2, 2023Exercised options 24,000 shares at $9.47 of Syndax Pharmaceuticals Inc¹³
Aug 2, 2023Sold 24,000 shares at $20.46 of Syndax Pharmaceuticals Inc¹³
Aug 2, 2023Exercised options 24,000 shares at $7.88 of Syndax Pharmaceuticals Inc¹³
Aug 2, 2023Sold 35,000 shares at $20.46 of Syndax Pharmaceuticals Inc¹³
Aug 2, 2023Exercised options 35,000 shares at $7.11 of Syndax Pharmaceuticals Inc¹³
Feb 2, 2023Granted 16,000 shares of Syndax Pharmaceuticals Inc¹⁴
Jan 3, 2023Granted 38,073 shares of Karuna Therapeutics¹⁵
Feb 2, 2022Granted 16,000 shares of Syndax Pharmaceuticals Inc¹⁶

The numbers on this page point here. Each one links to the record it came from.